Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385876617> ?p ?o ?g. }
Showing items 1 to 88 of
88
with 100 items per page.
- W4385876617 endingPage "93" @default.
- W4385876617 startingPage "84" @default.
- W4385876617 abstract "Objectives: Numerous tiny receptor tyrosine kinase inhibitors have been reported as anticancer medications over the past 10 years. However, a lot of them lack effectiveness in vivo, selectivity, or do not last long before developing resistance. Methods: We used molecular modeling research to improve the pharmacophore to get beyond these limitations. For the purpose of linking the chemical makeup of pyrazolyl thiazolinone analogs with their anticancer activity, quantitative structure activity relationship (QSAR) investigations in two dimensions (2D) and three dimensions (3D) were carried out. Pyrazolyl thiazolinone pharmacophore’s stearic, electronic, and hydrophobic requirements were calculated using 3D QSAR. Results: By leveraging the findings of QSAR investigations, the pharmacophore was refined and new chemical entities (NCEs) were generated. The r2 and q2 values obtained for the best model No. 4 of 2D QSAR were 0.9244 and 0.8701, respectively. A drug-like pharmacokinetic profile was ensured by studying the binding affinities of proposed NCEs on epidermal growth factor receptor-TK using docking studies and estimating their absorption, distribution, metabolism, and excretion features. Conclusion: When statistical significance is closely examined, predictability of the model and its residuals (actual activity minus predicted activity) is found to be close to zero, leading us to draw the conclusion that the logic behind the design of NCEs was determined to be sound." @default.
- W4385876617 created "2023-08-17" @default.
- W4385876617 creator A5003101283 @default.
- W4385876617 creator A5030647634 @default.
- W4385876617 creator A5045871175 @default.
- W4385876617 creator A5048003408 @default.
- W4385876617 creator A5056704117 @default.
- W4385876617 creator A5065402792 @default.
- W4385876617 creator A5092649414 @default.
- W4385876617 date "2023-08-07" @default.
- W4385876617 modified "2023-09-25" @default.
- W4385876617 title "DESIGN OF POTENT ANTICANCER MOLECULES COMPRISING PYRAZOLYL-THIAZOLINONE ANALOGS USING MOLECULAR MODELLING STUDIES FOR PHARMACOPHORE OPTIMIZATION" @default.
- W4385876617 cites W1531524766 @default.
- W4385876617 cites W1571439140 @default.
- W4385876617 cites W1970955548 @default.
- W4385876617 cites W1975875826 @default.
- W4385876617 cites W1978379892 @default.
- W4385876617 cites W1981737096 @default.
- W4385876617 cites W1999606433 @default.
- W4385876617 cites W2023782921 @default.
- W4385876617 cites W2024213882 @default.
- W4385876617 cites W2053106209 @default.
- W4385876617 cites W2058620780 @default.
- W4385876617 cites W2069506489 @default.
- W4385876617 cites W2077804275 @default.
- W4385876617 cites W2079398727 @default.
- W4385876617 cites W2086480844 @default.
- W4385876617 cites W2128245586 @default.
- W4385876617 cites W2133051701 @default.
- W4385876617 cites W2135732933 @default.
- W4385876617 cites W2147421370 @default.
- W4385876617 cites W2152121191 @default.
- W4385876617 cites W2155349252 @default.
- W4385876617 cites W2163646378 @default.
- W4385876617 cites W2950243794 @default.
- W4385876617 cites W4211165734 @default.
- W4385876617 cites W4235755332 @default.
- W4385876617 doi "https://doi.org/10.22159/ajpcr.2023.v16i8.47665" @default.
- W4385876617 hasPublicationYear "2023" @default.
- W4385876617 type Work @default.
- W4385876617 citedByCount "0" @default.
- W4385876617 crossrefType "journal-article" @default.
- W4385876617 hasAuthorship W4385876617A5003101283 @default.
- W4385876617 hasAuthorship W4385876617A5030647634 @default.
- W4385876617 hasAuthorship W4385876617A5045871175 @default.
- W4385876617 hasAuthorship W4385876617A5048003408 @default.
- W4385876617 hasAuthorship W4385876617A5056704117 @default.
- W4385876617 hasAuthorship W4385876617A5065402792 @default.
- W4385876617 hasAuthorship W4385876617A5092649414 @default.
- W4385876617 hasBestOaLocation W43858766171 @default.
- W4385876617 hasConcept C164126121 @default.
- W4385876617 hasConcept C185592680 @default.
- W4385876617 hasConcept C202751555 @default.
- W4385876617 hasConcept C21951064 @default.
- W4385876617 hasConcept C55493867 @default.
- W4385876617 hasConcept C56173144 @default.
- W4385876617 hasConcept C69366308 @default.
- W4385876617 hasConcept C70721500 @default.
- W4385876617 hasConcept C71240020 @default.
- W4385876617 hasConcept C86803240 @default.
- W4385876617 hasConceptScore W4385876617C164126121 @default.
- W4385876617 hasConceptScore W4385876617C185592680 @default.
- W4385876617 hasConceptScore W4385876617C202751555 @default.
- W4385876617 hasConceptScore W4385876617C21951064 @default.
- W4385876617 hasConceptScore W4385876617C55493867 @default.
- W4385876617 hasConceptScore W4385876617C56173144 @default.
- W4385876617 hasConceptScore W4385876617C69366308 @default.
- W4385876617 hasConceptScore W4385876617C70721500 @default.
- W4385876617 hasConceptScore W4385876617C71240020 @default.
- W4385876617 hasConceptScore W4385876617C86803240 @default.
- W4385876617 hasLocation W43858766171 @default.
- W4385876617 hasOpenAccess W4385876617 @default.
- W4385876617 hasPrimaryLocation W43858766171 @default.
- W4385876617 hasRelatedWork W1987468898 @default.
- W4385876617 hasRelatedWork W2516214333 @default.
- W4385876617 hasRelatedWork W2912616811 @default.
- W4385876617 hasRelatedWork W2998424449 @default.
- W4385876617 hasRelatedWork W3015543451 @default.
- W4385876617 hasRelatedWork W3016438405 @default.
- W4385876617 hasRelatedWork W3111155976 @default.
- W4385876617 hasRelatedWork W3164829341 @default.
- W4385876617 hasRelatedWork W4210933286 @default.
- W4385876617 hasRelatedWork W4213067368 @default.
- W4385876617 isParatext "false" @default.
- W4385876617 isRetracted "false" @default.
- W4385876617 workType "article" @default.